Table 3.

Demographic characteristics of the patients who were developed mortality attributed to candida infection and surveillance data

	Mortality			Survival			P value
	N	%		N	%
Gender
Female	26	53,1		3	21,4		0,04*
Male	23	46,9		11	78,6
	Mean	St.D	Min-Max	Mean	St.D	Min-Max
Age	75	12,39	37-95	53,5	29,23	14-89	0*
APACHE II Scores	27,61	8,02	10-50	14,2	7,22	4-30	0*
Hospital day	45,43	37,67	5-190	51,5	34,1	10-130	0,59
Hospital day in ICU	38,61	39,28	0-190	12,8	14,89	0-47	0,02*
CVC day	20,02	29,57	0-129	10,14	22,19	0-84	0,25
UC day	26,41	30,09	0-129	9,9	16,21	0-52	0,05
MV day	15,27	27,97	0-121	3,43	10,02	0-37	0,12
Antibiotic# day	16,53	14,51	1-67	10	9,46	0-30	0,11

CVC: Central venous catheter, UC: Urinary catheter, ICU: Intensive care unit, MR: Mechanical ventilation

^*Statistically significant

^#The duration of antibiotic therapy are used before positive culture in patients, the duration of antibiotic therapy are used during follow-up period in cohorts